Veeda Group Transitions to New Brand Identity as Veeda Lifesciences

Veeda Group Unveils New Identity as Veeda Lifesciences

In a significant step in its evolution, Veeda Group has officially rebranded itself as Veeda Lifesciences, introducing a fresh logo and updated brand identity. This change is not merely cosmetic but symbolizes a transformation in the company's focus,
reflecting its growth from being a contract research organization (CRO) focused on generic drugs to a comprehensive service provider in drug development, including both generics and innovative new chemical entities.

A New Chapter for Veeda Lifesciences

The new branding aims to integrate various sectors of Veeda's operations under one cohesive identity. The company now operates through four strategic business units, which include: clinical trials, healthy volunteer services, biopharmaceutical services, and preclinical and non-clinical testing services.
This strategic structure allows Veeda Lifesciences to offer integrated research services across the entirety of the drug development process, making it an indispensable partner for pharmaceutical and biotech companies alike.

Detailed Service Offerings

Veeda Lifesciences consolidates its various entities — Veeda Clinical Research, Health Data Specialists, and Bioneeds India — into one single brand that promises a seamless experience for clients at every stage of drug development. This involves services from initial discovery and preclinical phases through to advanced clinical development stages.
This transformation illustrates Veeda's commitment to expanding its capabilities: moving from local markets to a global presence, and evolving from small molecule drugs to biologics. The company is also actively transitioning to a CRO-CDMO model, capitalizing on the power of artificial intelligence and real-world data.

Leadership Insights

Dr. Mahesh Bhalgat, the CEO and General Manager of Veeda Lifesciences, commented on this milestone, stating, “The name Veeda Lifesciences and the new logo are designed to be modern and dynamic. They symbolize our progressive approach and dedication to fundamental values and mission.” He added that this rebranding adds aspirational value to the organization’s growth trajectory while underscoring its commitment to innovation, excellence, and customer satisfaction.

Expansion and Growth

Since its inception in 2004 in India, Veeda Lifesciences has substantially expanded its footprint. The firm now operates in five countries and conducts trials across 26 different geographies. The strategic acquisition of Bioneeds in 2021 marked a major expansion into preclinical services, further diversifying the array of research services offered by the company.

Today, Veeda Lifesciences is well-positioned to cater to the needs of global sponsors, including top-tier pharmaceutical companies, with a robust range of offerings that support biopharmaceutical development.

Future Ambitions

As it moves forward, Veeda Lifesciences focuses on continuing to diversify its service base and respond to the ever-evolving requirements of its clients. The firm remains committed to delivering quality and advancing its scientific capabilities by continuously investing in cutting-edge technologies and skilled personnel.

In conclusion, the transition to Veeda Lifesciences symbolizes more than just a name change; it reflects a comprehensive commitment to enhancing drug development processes, addressing both the growing demands of the pharmaceutical industry and the healthcare ecosystem worldwide.